SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Toevoegen aan een lijst
Financiën Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Aandelen
300760
CNE100003G67
Geavanceerde medische apparatuur & technologie
|
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 288,8 CNY | +1,30% |
|
+6,42% | -0,62% |
Totale waarde
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 221.134 | 517.884 | 461.774 | 382.132 | 351.450 | 349.273 | - | - |
| Bedrijfswaarde 1 | 206.861 | 502.020 | 446.498 | 359.043 | 332.776 | 317.142 | 308.179 | 287.654 |
| K/w-verhouding | 47,2 x | 77,8 x | 57,8 x | 39,8 x | 30,4 x | 25 x | 20,8 x | 18,7 x |
| Dividendrendement | 0,82% | 0,59% | 0,92% | 1,42% | 0,52% | 2,3% | 2,7% | - |
| Marktkapitalisatie/omzet | 13,4 x | 24,6 x | 18,3 x | 12,6 x | 10,1 x | 8,67 x | 6,86 x | 5,99 x |
| Bedrijfswaarde/omzet | 12,5 x | 23,9 x | 17,7 x | 11,8 x | 9,53 x | 7,87 x | 6,05 x | 4,93 x |
| Bedrijfswaarde/EBITDA | 35,8 x | 63,3 x | 45,7 x | 30,4 x | 23,8 x | 19,8 x | 16,2 x | 12,8 x |
| Bedrijfswaarde/FCF | 52,4 x | 65,3 x | 58,6 x | 34,9 x | 39,6 x | 26 x | 21,4 x | 17 x |
| FCF Yield | 1,91% | 1,53% | 1,71% | 2,87% | 2,52% | 3,84% | 4,66% | 5,88% |
| Price to Book | 11,9 x | 22,2 x | 17,2 x | 12 x | 10,6 x | 7,25 x | 5,77 x | - |
| Aantal aandelen (in duizenden) | 1.215.691 | 1.215.691 | 1.212.643 | 1.209.393 | 1.209.393 | 1.209.393 | - | - |
| Referentieprijs 2 | 181,9 | 426,0 | 380,8 | 316,0 | 290,6 | 288,8 | 288,8 | 288,8 |
| Datum van publicatie | 27/02/20 | 28/04/21 | 19/04/22 | 27/04/23 | 26/04/24 | - | - | - |
1CNY in Miljoen2CNY
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 16.556 | 21.026 | 25.270 | 30.366 | 34.932 | 40.291 | 50.930 | 58.290 |
| EBITDA 1 | 5.784 | 7.930 | 9.766 | 11.796 | 13.995 | 16.021 | 19.044 | 22.479 |
| Bedrijfsresultaat (EBIT) 1 | 5.379 | 7.455 | 9.066 | 10.991 | 13.070 | 15.495 | 18.535 | 21.495 |
| Operationele Marge | 32,49% | 35,46% | 35,88% | 36,19% | 37,42% | 38,46% | 36,39% | 36,88% |
| Resultaat voor belastingen (EBT) 1 | 5.368 | 7.438 | 9.017 | 10.954 | 13.011 | 15.922 | 19.077 | 22.524 |
| Nettowinst (verlies) 1 | 4.681 | 6.658 | 8.002 | 9.607 | 11.582 | 13.988 | 16.789 | 19.646 |
| Nettomarge | 28,27% | 31,66% | 31,66% | 31,64% | 33,16% | 34,72% | 32,97% | 33,7% |
| WPA 2 | 3,850 | 5,476 | 6,587 | 7,937 | 9,558 | 11,54 | 13,85 | 15,47 |
| Free Cash Flow 1 | 3.949 | 7.690 | 7.618 | 10.299 | 8.395 | 12.189 | 14.367 | 16.918 |
| FCF-marge | 23,85% | 36,58% | 30,15% | 33,92% | 24,03% | 30,25% | 28,21% | 29,02% |
| Kasstroomconversie (ebitda) | 68,27% | 96,97% | 78% | 87,31% | 59,99% | 76,08% | 75,44% | 75,26% |
| Kasstroomconversie (nettowinst) | 84,37% | 115,51% | 95,21% | 107,2% | 72,48% | 87,14% | 85,57% | 86,12% |
| Dividend per aandeel 2 | 1,500 | 2,500 | 3,500 | 4,500 | 1,500 | 6,649 | 7,810 | - |
| Datum van publicatie | 27/02/20 | 28/04/21 | 19/04/22 | 27/04/23 | 26/04/24 | - | - | - |
1CNY in Miljoen2CNY
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: december | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 5.878 | 6.943 | 8.412 | 15.356 | 7.940 | 7.070 | 15.010 | 8.364 | 10.111 | 18.476 | 8.828 | 7.628 | 16.456 | 9.373 | 11.739 | 11.016 | 10.027 | - | - |
| EBITDA | 1.330 | 2.560 | 3.502 | - | 3.213 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Bedrijfsresultaat (EBIT) 1 | 1.471 | 2.402 | 3.604 | 6.005 | 3.214 | 1.771 | - | 2.900 | 4.430 | - | 3.871 | 1.869 | - | 3.572 | 4.167 | 4.513 | - | - | - |
| Operationele Marge | 25,02% | 34,59% | 42,84% | 39,11% | 40,48% | 25,06% | - | 34,67% | 43,81% | - | 43,85% | 24,5% | - | 38,11% | 35,5% | 40,97% | - | - | - |
| Resultaat voor belastingen (EBT) | 1.434 | 2.406 | 3.603 | 6.008 | 3.220 | 1.725 | 4.945 | - | 4.422 | 7.310 | 3.877 | 1.824 | 5.701 | - | - | - | - | - | - |
| Nettowinst (verlies) | 1.339 | 2.105 | 3.183 | 5.288 | 2.815 | 1.505 | 4.320 | - | 3.871 | 6.442 | 3.392 | 1.748 | 5.140 | - | - | - | - | - | - |
| Nettomarge | 22,77% | 30,32% | 37,83% | 34,43% | 35,45% | 21,29% | 28,78% | - | 38,28% | 34,87% | 38,43% | 22,91% | 31,24% | - | - | - | - | - | - |
| WPA 2 | 1,105 | 1,738 | 2,631 | - | 2,330 | 1,240 | - | 2,125 | 3,191 | - | 2,803 | 1,440 | - | 2,609 | 3,485 | 3,450 | 1,810 | - | - |
| Dividend per aandeel 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0,5630 | - | - |
| Datum van publicatie | 19/04/22 | 19/04/22 | 19/08/22 | 19/08/22 | 27/10/22 | 27/04/23 | 27/04/23 | 27/04/23 | 29/08/23 | 29/08/23 | 27/10/23 | 26/04/24 | 26/04/24 | 26/04/24 | - | - | - | - | - |
1CNY in Miljoen2CNY
Geschatte gegevens
Balans
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | - | - | - | - | - | - | - | - |
| Nettokaspositie 1 | 14.273 | 15.865 | 15.276 | 23.088 | 18.673 | 32.131 | 41.094 | 61.619 |
| Hefboom (schuld/ebitda) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 3.949 | 7.690 | 7.618 | 10.299 | 8.395 | 12.189 | 14.367 | 16.918 |
| ROE (netto-inkomsten/eigen vermogen) | 27,9% | 32,3% | 31,9% | 33,4% | 33,6% | 31,4% | 30,8% | 25,9% |
| ROA (netto-inkomsten/totale activa) | 19,8% | 22,6% | 22,4% | 22,6% | - | 23,6% | 24,1% | - |
| Totale activa 1 | 23.625 | 29.470 | 35.705 | 42.424 | - | 59.303 | 69.661 | - |
| Nettoactief per aandeel 2 | 15,30 | 19,10 | 22,20 | 26,40 | 27,30 | 39,80 | 50,00 | - |
| Cashflow per aandeel 2 | 3,880 | 7,300 | 7,400 | 10,00 | 9,120 | 11,90 | 13,60 | - |
| Capex 1 | 773 | 1.180 | 1.381 | 1.842 | 2.667 | 1.678 | 1.751 | 2.736 |
| Capex/omzet | 4,67% | 5,61% | 5,46% | 6,07% | 7,63% | 4,16% | 3,44% | 4,69% |
| Datum van publicatie | 27/02/20 | 28/04/21 | 19/04/22 | 27/04/23 | 26/04/24 | - | - | - |
1CNY in Miljoen2CNY
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
B+
Verkoop
Koop
Gemiddeld advies
Kopen
Aantal analisten
27
Laatste slotkoers
288,8
CNY
Gemiddelde koersdoel
395,6
CNY
Spread / Gemiddelde doel
+36,98%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| -0,62% | 48,2 mld. | |
| +8,07% | 219 mld. | |
| +6,59% | 183 mld. | |
| +11,26% | 133 mld. | |
| +26,57% | 108 mld. | |
| +0,65% | 63,06 mld. | |
| +13,35% | 52,02 mld. | |
| -0,93% | 40,37 mld. | |
| +11,54% | 39,35 mld. | |
| +26,76% | 32,03 mld. |
- Beurs
- Aandelen
- Koers 300760
- Financiën Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
